Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Cancer Drugs in the United States: Justum Pretium—The Just PriceJournal of clinical oncology, 2013-10, Vol.31 (28), p.3600-3604 [Peer Reviewed Journal]2014 INIST-CNRS ;2013 by American Society of Clinical Oncology 2013 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2013.49.1845 ;PMID: 23650428Full text available |
|
2 |
Material Type: Article
|
How Much Longer Will We Put Up With $100,000 Cancer Drugs?Cell, 2017-02, Vol.168 (4), p.579-583 [Peer Reviewed Journal]2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2017.01.034 ;PMID: 28187281Full text available |
|
3 |
Material Type: Article
|
Cancer drugs: high price, uncertain valueBMJ (Online), 2017-10, Vol.359, p.j4543-j4543 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2017 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.j4543 ;PMID: 28978508Full text available |
|
4 |
Material Type: Article
|
An urgent call to raise the bar in oncologyBritish journal of cancer, 2021-11, Vol.125 (11), p.1477-1485 [Peer Reviewed Journal]2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-021-01495-7 ;PMID: 34400802Full text available |
|
5 |
Material Type: Article
|
Limits on Medicare's Ability to Control Rising Spending on Cancer DrugsThe New England journal of medicine, 2009-02, Vol.360 (6), p.626-633 [Peer Reviewed Journal]Copyright © 2009 Massachusetts Medical Society. All rights reserved. ;2009 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMhpr0807774 ;PMID: 19176475 ;CODEN: NEJMAGFull text available |
|
6 |
Material Type: Article
|
The Myth of the Free Market for PharmaceuticalsThe New England journal of medicine, 2024-04, Vol.390 (16), p.1448-1450 [Peer Reviewed Journal]Copyright © 2024 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp2313400 ;PMID: 38647106Full text available |
|
7 |
Material Type: Article
|
The Future of Drug-Pricing TransparencyThe New England journal of medicine, 2021-02, Vol.384 (6), p.489-491 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp2033734 ;PMID: 33440087Full text available |
|
8 |
Material Type: Article
|
Comparative Approaches to Drug PricingAnnual review of public health, 2020-04, Vol.41 (1), p.499-512 [Peer Reviewed Journal]ISSN: 0163-7525 ;EISSN: 1545-2093 ;DOI: 10.1146/annurev-publhealth-040119-094305 ;PMID: 31874070Full text available |
|
9 |
Material Type: Article
|
Drug-Pricing Debate Redux — Should Cost-Effectiveness Analysis Be Used Now to Price Pharmaceuticals?The New England journal of medicine, 2021-11, Vol.385 (21), p.1923-1924 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp2113323 ;PMID: 34767318Full text available |
|
10 |
Material Type: Article
|
Build Back Better Act could affect US community-based oncology practicesThe lancet oncology, 2022-01, Vol.23 (1), p.19-19 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00691-4 ;PMID: 34838185Full text available |
|
11 |
Material Type: Article
|
A New Way to Contain Unaffordable Medication Costs — Exercising the Government’s Existing RightsThe New England journal of medicine, 2022-03, Vol.386 (12), p.1104-1106 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp2117102 ;PMID: 35139270Full text available |
|
12 |
Material Type: Article
|
Postmarket policy considerations for biosimilar oncology drugsThe lancet oncology, 2016, Vol.17 (1), p.e31-e38 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 1, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(15)00381-2 ;PMID: 26758759Full text available |
|
13 |
Material Type: Article
|
US drug importation plan hits snagThe Lancet (British edition), 2021-06, Vol.397 (10291), p.2240-2240 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01334-9 ;PMID: 34119053Full text available |
|
14 |
Material Type: Article
|
The challenge of biosimilarsAnnals of oncology, 2008-03, Vol.19 (3), p.411-419 [Peer Reviewed Journal]2007 European Society for Medical Oncology ;The Author 2007. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org 2008 ;2008 INIST-CNRS ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdm345 ;PMID: 17872902Full text available |
|
15 |
Material Type: Article
|
Regulating Drug Prices while Increasing InnovationThe New England journal of medicine, 2021-11, Vol.385 (21), p.1921-1923 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp2113764 ;PMID: 34767322Full text available |
|
16 |
Material Type: Article
|
Advancing Legislation on Drug Pricing — Is There a Path Forward?The New England journal of medicine, 2019-11, Vol.381 (22), p.2081-2084 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1914044 ;PMID: 31774951Full text available |
|
17 |
Material Type: Article
|
Which Drug Prices Should Medicare Negotiate? A “Too Little” or “Too Late” ApproachThe New England journal of medicine, 2019-11, Vol.381 (22), p.2084-2086 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1912736 ;PMID: 31774952Full text available |
|
18 |
Material Type: Article
|
Importing Prescription Drugs from Canada — Legal and Practical Problems with the Trump Administration’s ProposalThe New England journal of medicine, 2020-05, Vol.382 (19), p.1777-1779 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp2000464 ;PMID: 32374960Full text available |
|
19 |
Material Type: Article
|
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and CanadaThe oncologist (Dayton, Ohio), 2019-04, Vol.24 (4), p.537-548 [Peer Reviewed Journal]AlphaMed Press 2019 ;AlphaMed Press 2019. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2018-0341 ;PMID: 30842244Full text available |
|
20 |
Material Type: Article
|
Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug–Pricing BoardsThe Milbank quarterly, 2021-12, Vol.99 (4), p.1162-1197 [Peer Reviewed Journal]2021 Milbank Memorial Fund ;2021 Milbank Memorial Fund. ;ISSN: 0887-378X ;EISSN: 1468-0009 ;DOI: 10.1111/1468-0009.12533 ;PMID: 34375015Full text available |